Acquired immunodeficiency syndrome-related systemic non-Hodgkin's lymphoma.
Bower
M
M
Department of Oncology, Chelsea & Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK. m.bower@ic.ac.uk
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000453:epidemiology / Q000821:virology; D020031:Epstein-Barr Virus Infections / Q000150:complications; D016259:Genes, myc; D016158:Genes, p53; D006566:Herpesviridae Infections / Q000150:complications; D019288:Herpesvirus 8, Human; D006801:Humans; D016867:Immunocompromised Host; D007167:Immunotherapy; D015994:Incidence; D016483:Lymphoma, AIDS-Related / Q000453:epidemiology* / Q000821:virology; D016393:Lymphoma, B-Cell / Q000453:epidemiology / Q000821:virology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000453:epidemiology / Q000821:virology; D008228:Lymphoma, Non-Hodgkin / Q000453:epidemiology* / Q000821:virology; D008297:Male; D011379:Prognosis; D012307:Risk Factors; D014178:Translocation, Genetic
D000998:Antiviral Agents